P1228: GENOME-WIDE CRISPR-CAS9 SCREENING IDENTIFIES THERAPEUTIC TARGETS FOR MATURE T-CELL MALIGNANCIES

• Sanna Timonen,
• Vanessa Rebecca Gasparini,
• Ella Piekkari,
• Olli Dufva,
• Shady Awad,
• Yevhen Akimov,
• Jana von Jan,
• Till Braun,
• Aleksandr Ianevski,
• Matti Kankainen,
• Jay Klievink,
• Marco Herling,
• Tero Aittokallio,
• Satu Mustjoki

Affiliations

Sanna Timonen

1 Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Vanessa Rebecca Gasparini

4 Department of Medicine, Hematology and Clinical Immunology Branch, University of Padova, Padova, Italy

Ella Piekkari

1 Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Olli Dufva

1 Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Shady Awad

1 Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Yevhen Akimov

3 Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland

Jana von Jan

7 Department I of Internal Medicine, Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf (CIO ABCD), University Hospital Cologne, University of Cologne, Cologne, Germany

Till Braun

7 Department I of Internal Medicine, Center for Integrated Oncology Aachen-Bonn-Cologne-Duesseldorf (CIO ABCD), University Hospital Cologne, University of Cologne, Cologne, Germany

Aleksandr Ianevski

3 Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland

Matti Kankainen

1 Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Jay Klievink

1 Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Marco Herling

8 Department of Hematology, Cellular Therapy, and Hemostaseology, University of Leipzig, Leipzig, Germany

Tero Aittokallio

3 Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland

Satu Mustjoki

1 Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland